CureVac Shares Fall After Cutting COVID-19 Vaccine Production Plans

CureVac BV has canceled contract manufacturing deals for its experimental COVID-19 vaccine with two prospective partners.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.